Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
19.38
+0.15 (0.78%)
At close: Feb 27, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18
Pharmaceutical Retail
3.15B2.61B2.23B1.56B-
Pharmaceutical Retail Growth
20.58%16.94%43.19%--
Pharmaceutical Agent
795.92M742.32M733.76M588.31M-
Pharmaceutical Agent Growth
7.22%1.17%24.72%--
Terminal Collection
344.12M291.35M233.64M121.06M-
Terminal Collection Growth
18.11%24.70%93.00%--
Information Service
273.18K418.63K1.65M636.11K-
Information Service Growth
-34.74%-74.62%159.26%--
Industrial Production
165.28M77.74M---
Industrial Production Growth
112.62%----
Unallocated Other Operating Income
77.81M74.42M60.74M69.46M-
Unallocated Other Operating Income Growth
4.55%22.53%-12.55%--
Total
4.53B3.80B3.26B2.34B-
Total Growth
19.34%16.39%39.50%--

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18
China
---2.34B1.93B
China Growth
---21.12%26.84%
East China
3.67B3.06B2.63B--
East China Growth
19.97%16.20%---
South China
70.75M62.53M50.05M--
South China Growth
13.13%24.95%---
Central China
150.11M132.97M113.42M--
Central China Growth
12.89%17.23%---
North China
122.44M93.69M88.97M--
North China Growth
30.69%5.30%---
North-east Area
175.04M156.19M135.27M--
North-east Area Growth
12.07%15.47%---
North-west Region
89.63M71.49M66.45M--
North-west Region Growth
25.39%7.57%---
Southwest Region
170.20M143.88M113.85M--
Southwest Region Growth
18.29%26.37%---
Overseas
4.09M1.55M---
Overseas Growth
164.13%----
Unallocated
77.81M74.42M60.74M--
Unallocated Growth
4.55%22.53%---
Total
4.53B3.80B3.26B2.34B1.93B
Total Growth
19.34%16.39%39.50%21.12%26.84%
Source: S&P Global Market Intelligence.